KIAA1549: BRAF fusion gene in pediatric brain tumors of various histogenesis

Pediatric Blood and Cancer

Volumn 62, Issue 4, 2015, Pages 724-727

  Antonelli, Manila ^a   Badiali, Manuela ^b   Moi, Loredana ^b   Buttarelli, Francesca R ^c   Baldi, Caterina ^a   Massimino, Maura ^d   Sanson, Marc ^e,f   Giangaspero, Felice ^a,g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Osp Regionale per le Microcitemie   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e SORBONNE UNIVERSITÉ   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g IRCCS NEUROMED   (Italy)

Author keywords

BrafV600E; H3F3A mutation; KIAA1549:BRAF fusion gene; Pediatric brain tumors; Pediatric gliomas

Indexed keywords

ADOLESCENT; ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA; ARTICLE; ASTROCYTOMA; ATYPICAL TERATOID RHABDOID TUMOR; BRAF GENE; BRAIN TUMOR; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA EXTRACTION; EPENDYMOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA; HISTOGENESIS; HUMAN; KIAA1549 GENE; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; PLEOMORPHIC XANTHOASTROCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; RNA EXTRACTION; SCHOOL CHILD; TUMOR GENE; FEMALE; GENETICS; INFANT; MALE; METABOLISM; PATHOLOGY;

B RAF KINASE; BRAF PROTEIN, HUMAN; ONCOPROTEIN;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS B-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84923207800     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25272     Document Type: Article

References (12)

1. Schindler G, Capper D, Meyer J, et al. Analysis of BRAF V600E mutation in 1, 320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011; 121:397-405.
2. Jones DT, Kocialkowski S, Liu L, et al. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 2009; 28:2119Y23.
3. Bar E, Lin A, Tihan T, et al. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 2008; 67:878-8887.
4. Jones DT, Kocialkowski S, Liu L, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008; 68:8673-8677.
5. Forshew T, Tatevossian RG, Lawson AR, et al. Activation of the ERK/MAPK pathway: A signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 2009; 218:172-181.
6. Wan PT, Garnett MJ, Roe SM, et al. Cancer Genome Project. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 2004; 116:855-867.
7. Jones DT, Hutter B, Jäger N, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 2013; 45:927-932.
8. Badiali M, Gleize V, Paris S, et al. KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults. Brain Pathol 2012; 22:841-847.
9. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7:233-245.
10. Kim YH, Nonoguchi N, Paulus W, et al. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss. Brain Pathol 2012; 22:834-840.
11. Lin A, Rodriguez FJ, Karajannis MA, et al. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol 2012; 1:66-72.
12. Schiffman JD, Hodgson JG, VandenBerg SR, et al. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res 2010; 15:512-519.